Alnylam Pharmaceuticals Inc - Company Profile
Powered by 
All the data and insights you need on Alnylam Pharmaceuticals Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Alnylam Pharmaceuticals Inc Strategy Report
- Understand Alnylam Pharmaceuticals Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
The following section provides information on Alnylam Pharmaceuticals Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Alnylam Pharmaceuticals Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Amy W. Schulman
Chairman Executive BoardMr. Amy W. Schulman has been the Chairman of the company since January 2023. Prior to this, he served as the Board of Directors of the company. Previously, he served as the Managing Partner, Polaris Partners; Co-founder, Executive Chair, and former Chief Executive Officer of Lyndra Therapeutics.
Yvonne Greenstreet, MBChB
Chief Executive Officer; Director Executive BoardDr. Yvonne Greenstreet has been the Chief Executive Officer and Director of Alnylam Pharmaceuticals since 2022. Prior to this, she served as the President and Chief Operating Officer of the company since 2020. Before that, she served as the Senior Vice President and Head of Medicines Development at Pfizer. Previously, she served as the Senior Vice President and Chief of Strategy for Research and Development, Senior Vice President for Medicines Development, and Chief Medical Officer of Europe at GlaxoSmithKline plc.
Jeff Poulton
Chief Financial Officer; Executive Vice President Senior ManagementMr. Jeff Poulton has been the Chief Financial Officer and the Executive Vice President of the company since 2019. Prior to this, he was the Chief Financial Officer at Indigo Agriculture. Mr. Poulton also served as the Chief Financial Officer and a member of Shire.
Indrani Franchini
Chief Legal Officer; Executive Vice President; Secretary Senior ManagementMs. Indrani Franchini has been the Executive Vice President, Chief Legal Officer and Secretary of the company since 2022. Prior to this, she served as the Executive Vice President, Chief Compliance Officer at Alexion. Before that, she served as the Chief Compliance Officer and Assistant Corporate Secretary at Hess Corporation. Ms. Indrani also served in several positions including supporting the Global Pharmaceutical business at Pfizer.
Pushkal P. Garg, M.D.
Chief Medical Officer; Executive Vice President - Development & Medical Affairs Senior ManagementDr. Pushkal Garg has been the Chief Medical Officer and Executive Vice President of Development & Medical Affairs of the company since 2022. Previously, he served as the Senior Vice President of Clinical Development. Prior to this, he served as the Vice President, Global Clinical Research, Immunoscience at Bristol-Myers Squibb.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer